Clinical Trial

Determination of Metabolomic Profile Differences in Possible Sarcopenia Accompanying Fibromyalgia Syndrome in Women

Completed
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to determine the serum metabolome profile differences in the presence of possible sarcopenia in patients with fibromyalgia and to compare them with healthy individuals. In this way, it is aimed to contribute to the knowledge about the pathophysiology, diagnosis and treatment of these diseases.The main questions it aims to answer are: * Is there a difference in blood metabolite levels and metabolic pathways in fibromyalgia syndrome and possible sarcopenia accompanying fibromyalgia syndrome? * Based on these identified differences, can biomarkers be determined for these diseases?
Trial Details
NCT Number NCT07381348
Lead Sponsor Ankara City Hospital Bilkent
Collaborators: Saglik Bilimleri Universitesi
Conditions Fibromyalgia, Sarcopenia
Enrollment 66 participants
Start Date 2022-06-01
Primary Completion 2022-11-10 (estimated)
Study Completion 2023-05-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-02